EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 154 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $907,000 | -39.5% | 34,325 | +1.7% | 0.08% | -36.4% |
| Q2 2022 | $1,499,000 | -5.9% | 33,738 | +4.8% | 0.13% | +12.8% |
| Q1 2022 | $1,593,000 | -12.4% | 32,183 | -9.9% | 0.12% | 0.0% |
| Q4 2021 | $1,819,000 | -12.4% | 35,719 | -4.0% | 0.12% | -25.0% |
| Q3 2021 | $2,076,000 | +26.6% | 37,219 | -2.9% | 0.16% | +59.2% |
| Q2 2021 | $1,640,000 | +2.1% | 38,319 | -0.4% | 0.10% | -4.9% |
| Q1 2021 | $1,606,000 | +9.7% | 38,465 | +22.3% | 0.10% | -29.5% |
| Q4 2020 | $1,464,000 | +14.2% | 31,444 | +4.2% | 0.15% | +10.6% |
| Q3 2020 | $1,282,000 | -4.5% | 30,189 | +7.8% | 0.13% | -14.8% |
| Q2 2020 | $1,343,000 | +105.7% | 28,000 | +97.2% | 0.16% | +63.2% |
| Q1 2020 | $653,000 | – | 14,200 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |